期刊文献+

促甲状腺激素受体在甲状腺相关眼病球后组织中的基因和蛋白表达 被引量:4

Gene and protein expression of thyrotropin-receptor in retro-bulbar tissue from thyroid-associated ophthalmopathy
原文传递
导出
摘要 目的探讨促甲状腺激素受体(TSHR)在甲状腺相关眼病(TAO)患者球后脂肪和结缔组织中的基因和蛋白表达及其作用机制。方法实验组为TAO患者11例,对照组为非TAO患者10例,分别经手术获得TAO实验组及非TAO对照组患者的球后脂肪与结缔组织,提取总RNA,经RTPCR产物电泳观察TSHRmRNA的表达。基因表达阳性者进行免疫组织化学染色,观察其蛋白表达。结果从TAO实验组和非TAO对照组患者球后脂肪和结缔组织中提取总RNA,经RTPCR扩增TSHRmRNA片段,大小为521bp。TAO患者球后组织和结缔组织中TSHRmRNA阳性表达率为91%,非TAO对照组的阳性表达率为20%,二者比较差异有统计学意义(P=0.007)。在TAO患者组TSHR蛋白的阳性表达率为66.7%,而非TAO对照组患者无TSHR蛋白的表达。结论TAO实验组患者球后脂肪和结缔组织中TSHRmRNA呈高度表达,且有TSHR蛋白表达,而非TAO对照组均无表达,证实TAO患者球后组织中有活性TSHR蛋白存在,提示TSHR可能作为交叉抗原在TAO发病机制中起重要作用。 Objective To investigate gene and protein expression level of thyrotropin-receptor (TSHR) in retro-bulbar connective tissue and fat tissue in patients with thyroid-associated ophthalmopathy (TAO). Methods Retro-bulbar tissues specimens were obtained from 11 cases of TAO patients and 10 control cases during the operation. RNA was extracted from the tissue specimens using single-step method of acid guanidinium-thiocyanate-phenol-chloroform extraction and TSHR mRNA was analyzed by reverse transcription polymerase chain reaction (RT-PCR). Immunochemistry staining was performed in patients expressed TSHR, using a mouse polyclonal anti-TSHR peptide antibody to observe protein expression level of TSHR. Results The size of TSHR mRNA segment is 521 bp. The rate of TSHR mRNA expression in TAO retro-bulbar tissue was 91% and was 20% in the control cases, the former was significantly greater than the later. Protein expression rate was 66. 7% in TAO patients, and was negative in the controls. Conclusions High TSHR mRNA expression level and protein level in TAO retro-bulbar tissue and no expression in control tissue indicate that TSHR exists as a common antigen in the orbit and thyroid, and plays a key role in the pathogenesis of TAO.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2006年第2期155-158,共4页 Chinese Journal of Ophthalmology
基金 天津市自然科学基金资助项目(01360931)
关键词 受体 甲状腺激素 格雷夫斯病 脂肪组织 结缔组织 基因表达 Receptors,thyroid hormone Graves'disease Adipose tissue Connective tissue Gene expression
  • 相关文献

参考文献10

  • 1Megregor AM.Has the target autoantigen for Graves ophthalmopathy been found ? Lancet,1998,352:595-597.
  • 2Stadlmayr W,Spitzweg C,Bichlmair AM,et al.TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.Thyroid,1997,7:3-12.
  • 3Nagayama Y,Kaufman KD,Seto P,et al.Molecular cloning,sequence and functional expression of the cDNA for the human thyrotropin receptor.Biochem Biophys Res Commun,1989,165:1184-1190.
  • 4Paschke R,Ludgate M.The thyrotropin receptor in thyroid diseases.N Engl J Med,1997,337:1675-1681.
  • 5Sande JV,Parma J,Tonacchera M,et al.Somatic and germline mutation of the TSH receptor gene in thyroid disease.J Clin Endocrinol Metab,1995,80:2577-2579.
  • 6Heufelder AE.Pathogenesis of Graves' ophthalmopathy:recent controversies and progress.Eur J Endocrinol,1995,132:532-541.
  • 7Crisp MS,Lane C,Halliwell M,et al.Thyrotropin receptor transcripts in human adipose tissue.J Clin Endocrinol Metab,1997,82:2003-2005.
  • 8Burch HB,Selletti D,Bames SG,et al.Thyrotropin receptor antisera for the ditection of immunoreactive protein species in retroocular fibroblast obtained from patients with Graves'ophthalmopathy.J Clin Endocrinol Metab,1994,78:1384-1391.
  • 9Spitzweg C,Joba W,Hunt N,et al.Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.Eur J Endocrinol,1997,136:599-607.
  • 10Bahn RS,Dutton CM,Heufelder AE,et al.A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves'ophthalmopathy.J Clin Endocrinol Metab,1994,78:256-260.

同被引文献59

  • 1何剑峰,吴中耀,杨华胜,颜建华,毛羽翔,陈智聪,艾思明.甲状腺相关眼病339例临床分析[J].中华眼科杂志,2004,40(6):368-372. 被引量:20
  • 2孙丰源,赵红,魏楠,林思勇,张岩.手术显微镜在眼眶手术中的应用[J].中华眼科杂志,2006,42(1):60-61. 被引量:1
  • 3罗清礼,何为民,夏庆杰,曹桂群,闫乃红,王玲,张发强.甲状腺相关眼病患者眼眶组织糖皮质激素受体mRNA的表达[J].中华眼科杂志,2007,43(1):40-43. 被引量:12
  • 4Bartley GB.The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olrested County, Minnesota[J]. Trans Am Ophthalmo Soc,1994,92: 477-588.
  • 5Lira SL, Lim AK, Mumtaz M, et al. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease[J].Thyroid,2008,18(12): 1297-1301.
  • 6Douglas RS, Gianoukakis AG, Goldberg RA,et al. Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes[J]. Chn Exp Immunol,2007,148(1 ):64-71.
  • 7Jack Rootman编著,孙丰源主译.眼眶疾病[M].第2版.天津:天津科技翻译出版公司,2006:147-179.
  • 8Bartalena L,Baldeschi L,Dickinson AJ. Consensus statement of the European Group on Graves'orbitopathy (EUGOGO) on management of Graves'orbitopathy[J].{H}THYROID,2008.333-346.
  • 9Mourits MP,Prummel MF,Wiersinga WM. Clinical activity score as a guide in the management of patients with Graves'ophthalmopathy[J].{H}Clinical Endocrinology(Oxford),1997.9-14.
  • 10Jameson JL,De Groot LJ. Endocrinology, adult and pediatric[M].Philadelphia:Elsevier Health Sciences,2010.1565-1568.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部